| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 02/10/1998 | US5716838 Culture of microorganisms such as rhizobium, arthrobacter |
| 02/10/1998 | US5716644 Lyophilized solution containing erythropoietin, ammonium sulfate, ph 5-7 buffer |
| 02/10/1998 | US5716643 Large scale production of medicine coated crosslinked protein microspheres |
| 02/10/1998 | US5716640 Water in oil emulsion |
| 02/10/1998 | US5716639 A grain extract glycolipids; drugs, cosmetics, foods, nutrients; biocompatibility |
| 02/10/1998 | US5716637 Solid fat nanoemulsions as vaccine delivery vehicles |
| 02/10/1998 | US5716634 Clear, homogenized, flowable hydrogel of crosslinked N-vinyl lactam polymer |
| 02/10/1998 | US5716631 Solubilized within polymer matrix |
| 02/10/1998 | US5716625 Formulations and methods for reducing skin irritation |
| 02/10/1998 | US5716617 Concurrent purification of mixture |
| 02/10/1998 | US5716614 Administering complex containing lipophilic cationic polymer carrier which is attached to unsaturated fatty acid groups, biologically active material or drug and additional unsaturated fatty acids(or derivatives) |
| 02/10/1998 | US5716611 Topical formulation including water soluble emollient comprising ethoxylated higher aliphatic alcohol and ethoxylated cholesterol derivative |
| 02/10/1998 | US5716610 A mixture of water soluble vinyl polymer gel, amine alcohol dispersant, water and histamine phosphate is used topically to treat herpes labialis and/genitalis, chicken pox, heat and sun burn, aphthous stomatitis, allergic conjunctivitis |
| 02/10/1998 | US5716609 Therapeutic anti-inflammatory and analgesic composition containing nimesulide for use transdermally and a process for the manufacture thereof |
| 02/10/1998 | US5716608 Methods to inhibit acute radiation-induced skin damage |
| 02/10/1998 | US5716607 Preapplying a layer of biocompatible polymer |
| 02/10/1998 | US5716595 Intraperative, intravascular and endoscopic tumor and lesion detection and therapy with monovalent antibody fragments |
| 02/10/1998 | US5715835 Methods for treating and reducing the potential for cardiovascular disease using methioninase compositions |
| 02/10/1998 | US5715824 Biological apparatus comprising a vessel for foaming procedure |
| 02/10/1998 | CA2069760C Lipid formulation system |
| 02/10/1998 | CA1339670C Polyamide resin and resin-protide, and methods for preparation of reagents and of immunodiagnostic testing |
| 02/05/1998 | WO1998004917A1 Boron neutron capture therapy using pre-targeting methods |
| 02/05/1998 | WO1998004703A1 THE NucA PROTEIN OF HAEMOPHILUS INFLUENZAE AND THE GENE ENCODING THAT PROTEIN |
| 02/05/1998 | WO1998004341A1 Solubilizers, emulsifiers and dispersants |
| 02/05/1998 | WO1998004312A1 Novel methods for embolizing vascular sites with an embolizing composition comprising dimethylsulfoxide |
| 02/05/1998 | WO1998004294A2 Radiolabeled annexins |
| 02/05/1998 | WO1998004283A1 Antiprotozoal composition |
| 02/05/1998 | WO1998004242A2 Tumor delivery vehicles and method to enhance treatment of cystic tumors |
| 02/05/1998 | WO1997048384A3 Marking rapidly disintegrating dosage forms |
| 02/05/1998 | WO1997048369A3 Prophylactic and therapeutic treatment of skin sensitization and irritation |
| 02/05/1998 | WO1997038663A3 Buccal, non-polar spray or capsule |
| 02/05/1998 | WO1997032891A3 Conjugate for modifying interactions between proteins |
| 02/05/1998 | DE19631084A1 Verwendung von (Meth)acrylsäure-Copolymeren zur Erhöhung der Permeabilität der Schleimhaut Use of (meth) acrylic acid copolymers to increase the permeability of the mucosal |
| 02/05/1998 | CA2261791A1 Boron neutron capture therapy using pre-targeting methods |
| 02/05/1998 | CA2261718A1 Tumor delivery vehicles and method to enhance treatment of cystic tumors |
| 02/05/1998 | CA2260047A1 Novel methods for embolizing vascular sites with an embolizing composition comprising dimethylsulfoxide |
| 02/05/1998 | CA2232975A1 The nuca protein of haemophilus influenzae and the gene encoding that protein |
| 02/04/1998 | EP0822217A1 Heterotelechelic block copolymers and process for producing the same |
| 02/04/1998 | EP0822199A2 N-terminally monopegylated polypeptides and process for their preparation. |
| 02/04/1998 | EP0821970A1 Carrier composition for influencing the tight junction permeability |
| 02/04/1998 | EP0821965A2 Use of copolymers of (meth)accrylic and maleic acid for the manufacture of a medicament for enhancing the permeability of the mucose |
| 02/04/1998 | EP0821951A1 Process for preparing a bicarbonate-containing infusion- or dialysis solution |
| 02/04/1998 | EP0821686A1 Novel porphyrins and porphyrin synthesis techniques |
| 02/04/1998 | EP0821593A2 Conjugate of an active agent, a polyether and possibly a native protein regarded as acceptable by the body |
| 02/04/1998 | EP0821582A2 Controlled release tablet |
| 02/04/1998 | EP0730494B1 Particles for binding monovalent cations and their use |
| 02/04/1998 | EP0652967B1 Self-assembling replication defective hybrid virus particles |
| 02/04/1998 | CN1172434A Use of angiotensin II fragments and analogs thereof in tissue repair |
| 02/04/1998 | CN1172433A Sucralfate preparation |
| 02/04/1998 | CN1172429A Sustained-release drug delivery employing powdered hydrocolloid gum obtainable from higher plants |
| 02/03/1998 | US5714588 Enhancement of cellular attachment using H3 protein |
| 02/03/1998 | US5714586 Methods for the preparation of monomeric calicheamicin derivative/carrier conjugates |
| 02/03/1998 | US5714520 Propofol compostion containing edetate |
| 02/03/1998 | US5714512 Solution in a surfactant; for perfusions |
| 02/03/1998 | US5714484 α-(1,3-dicarbonylenol ether) methyl ketones as cysteine protease inhibitors |
| 02/03/1998 | US5714477 Homogenous, aqueous solution containing fatty monoglyceride; enhanced absorption/bioavailability, drug delivery |
| 02/03/1998 | US5714476 Process for preparing compositions containing neotrehalose |
| 02/03/1998 | US5714473 Chemotherapy; mixture with alkali metal citrate |
| 02/03/1998 | US5714316 Chimeric envelope proteins for viral targeting |
| 02/03/1998 | US5714167 Reversibly forming supramolecular complex of active agent with perturbant; drug delivery |
| 02/03/1998 | US5714166 Bioactive and/or targeted dendrimer conjugates |
| 02/03/1998 | US5714165 Blend of polyoxyethylene glycol and water soluble salt of copolymer of methyl vinyl ether and maleic (acid or anhydride) |
| 02/03/1998 | US5714162 Scopolamine patch |
| 02/03/1998 | US5714159 Block copolymer of glycolic acid-lactic acid and polyethylene glycol which is a biomedical barrier; useful for treating a person suffering from the condition of post srugical adhesion, defects in conduit, tissure wound etc |
| 02/03/1998 | US5714149 Crosslinked antibodies and processes for their preparation |
| 02/03/1998 | US5714148 Chemical compounds |
| 02/03/1998 | US5714142 Method and compositions for increasing the serum half-life of pharmacologically active agents by binding to transthyretin-selective ligands |
| 02/03/1998 | US5714138 Polyaspartamide derivatives as adsorbents for bile acids, polyaspartamide derivatives loaded with bile acids and process for their preparation and their use as pharmaceuticals |
| 02/03/1998 | CA2100836E Pharmaceutical composition |
| 02/03/1998 | CA2071262C Stabilized solid dosage forms of choline metal carboxymethylcellulose salicylate compositions |
| 01/29/1998 | WO1998003870A1 Diagnostic and therapeutic nucleotide or nucleoside photoaffinity compound modified antibodies, and use thereof |
| 01/29/1998 | WO1998003641A1 Transdermal transport of molecules |
| 01/29/1998 | WO1998003552A2 A multivalent major histocompatibility complex peptide fusion protein for modulating specific t cell function |
| 01/29/1998 | WO1998003267A1 A dispensing device and method for forming material |
| 01/29/1998 | WO1998003204A1 Covalent polar lipid conjugates with biologically-active compounds for use in salves |
| 01/29/1998 | WO1998003203A1 Water-insoluble porous particles of biocompatible substances and process for producing the same |
| 01/29/1998 | WO1998003202A1 Sorbefacients |
| 01/29/1998 | WO1998003184A1 Levan derivatives, their preparation, composition and applications including medical and food applications |
| 01/29/1998 | WO1998003162A1 Medicinal compositions |
| 01/29/1998 | WO1998003081A1 Method of improving the growth or the efficiency of feed conversion of an animal and compositions for use therein |
| 01/29/1998 | WO1997032609A3 Microencapsulated fluorinated gases for use as imaging agents |
| 01/29/1998 | CA2262009A1 Transdermal transport of molecules |
| 01/29/1998 | CA2261898A1 Diagnostic and therapeutic nucleotide or nucleoside photoaffinity compound modified antibodies, and use thereof |
| 01/29/1998 | CA2261662A1 Sorbefacients |
| 01/28/1998 | EP0821060A2 Diagnosis and therapy of human malign tumors based on E-cadherin mutations |
| 01/28/1998 | EP0820473A1 Biodegradable polyacetal polymers and formation and use |
| 01/28/1998 | EP0820470A1 Novel anti-aids immunotoxins |
| 01/28/1998 | EP0820469A1 Identification, purification and uses of leczymes and carbohydrate ligands |
| 01/28/1998 | EP0820462A1 Cleavage of rna using metal complexes |
| 01/28/1998 | EP0820308A2 Conjugate for treating inflammatory, infectious and/or skin diseases |
| 01/28/1998 | EP0820306A1 Pharmaceutical composition containing pectin and a phospholipid, used as an antidiarrheal and antiulcer agent |
| 01/28/1998 | EP0820304A1 Chlamydia vaccines |
| 01/28/1998 | EP0820300A1 Controlled release biodegradable nanoparticles containing insulin |
| 01/28/1998 | EP0820299A1 Formulations for il-12 |
| 01/28/1998 | EP0820294A1 Use of nitric oxide-releasing agents to treat impotency |
| 01/28/1998 | EP0820285A1 Methods and compositions for lipidization of hydrophilic molecules |
| 01/28/1998 | EP0820277A1 Powdered pharmaceutical formulations having improved dispersibility |
| 01/28/1998 | EP0820275A1 Cosmetic melanins |
| 01/28/1998 | EP0820270A1 Dispersible particulate system for desensitizing teeth |
| 01/28/1998 | EP0820269A1 Method for topical treatment of scar tissue and related tissue reaction to trauma |